Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023)
Pharvaris (PHVS) posted Other Non-Current Assets of $667959.6 for Q4 2023, up 12.38% on a QoQ basis from $594384.9 in Q4 2022, and up 12.38% year-over-year from $594384.9 in Q4 2022.
Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023) Analysis & Trends
Pharvaris' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $667959.6 for Q4 2023.
- Quarterly Other Non-Current Assets rose 12.38% year-over-year to $667959.6 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $667959.6 (up 12.38% YoY) and the FY2023 annual result came in at $671546.5, up 9.37% from the prior year.
- Other Non-Current Assets was $667959.6 for Q4 2023 at Pharvaris, up from $594384.9 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.4 million in Q4 2020 and bottomed at $6519.5 in Q4 2021.
- A 4-year average of $678666.4 and a median of $631172.3 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets plunged 99.55% — and 2022, when it jumped 9017.05%.
- Pharvaris' Other Non-Current Assets stood at $1.4 million in 2020, then plunged by 99.55% to $6519.5 in 2021, then soared by 9017.05% to $594384.9 in 2022, then gained by 12.38% to $667959.6 in 2023.
- Business Quant data shows PHVS's Other Non-Current Assets at $667959.6 in Q4 2023, $594384.9 in Q4 2022, and $6519.5 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 14.48 Mn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 667,959.63 |
| Dec 31, 2022 | 594,384.89 |
| Dec 31, 2021 | 6,519.49 |
| Dec 31, 2020 | 1.45 Mn |